If a pharmaceutical company agrees to supply the investigational treatment, the treating physician must next request permission to proceed from the FDA through a form FDA 3926, also known as the Individual Patient Expanded Access Investigational New Drug Application.
For a detailed explanation of how to fill out Form FDA 3926, click here.
NOTE: Internet Explorer is needed to access the most up-to-date form directly from FDA’s website. Accessing the form directly from FDA on Internet Explorer allows you to electronically fill out the information required.
Alternatively, to view or download a sample of FDA FORM 3926 click on the download button below. Please note this method of accessing the form does not facilitate electronically typing in the fields.